{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-087859","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2024-08-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.450732+00:00","generated_at":"2026-05-31T10:20:24.385179+00:00","sec_items":["4.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Cellectar restates 2022-2024 financials; warrant accounting error triggers non-reliance","bullets":["Board concludes FY2022, FY2023 audited and Q1-Q3 2023, Q1 2024 interim statements are unreliable.","Errors stem from accounting treatment of warrants issued in October 2022 financing.","Restatement required; company unable to estimate amount or effect at this time.","Filing of Q2 2024 Form 10-Q will be delayed pending restatement.","Discussed with current auditor Deloitte and former auditor Baker Tilly."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-087859","json":"https://secwatch.observer/filing/0001104659-24-087859.json","markdown":"https://secwatch.observer/filing/0001104659-24-087859.md","text":"https://secwatch.observer/filing/0001104659-24-087859.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924087859/0001104659-24-087859-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924087859/tm2421322d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:20:24.385179+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}